🇺🇸 FDA
Patent

US 11065218

Compositions and methods for treating chronic inflammation and inflammatory diseases

granted A61KA61K31/19A61K31/192

Quick answer

US patent 11065218 (Compositions and methods for treating chronic inflammation and inflammatory diseases) held by Infirst Healthcare Limited expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/19, A61K31/192, A61K31/196, A61K31/215